Medicus Pharma Ltd.

Analysis for Ticker: MDCX

Medicus Pharma Ltd is a biotechnology firm specialized in developing microneedle arrays for precision medicine in skin and prostate cancer treatments. The company generates zero revenue but managed to burn 35,4$ million in 2025 while accumulating a total deficit of 64,3$ million. Imagine a lemonade stand that has never sold one cup of juice but still pays the owner’s family 125.000$ every month just to stand by the empty pitchers. To get the cash to stay open the stand sells tiny pieces of itself at a 3,0% discount to a shadow bank that immediately sells those pieces to the neighbors. This internal math is a disaster because the more pieces they print the less every original piece is worth to the people who bought in early.